Vivoryon Therapeutics NV (STU:05Y) Future 3-5Y EPS without NRI Growth Rate : 13.12 (As of Sep. 21, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Vivoryon Therapeutics NV Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Vivoryon Therapeutics NV's Future 3-5Y EPS without NRI Growth Rate is 13.12.

Competitive Comparison of Vivoryon Therapeutics NV's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Vivoryon Therapeutics NV's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivoryon Therapeutics NV's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivoryon Therapeutics NV's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Vivoryon Therapeutics NV's Future 3-5Y EPS without NRI Growth Rate falls into.

Vivoryon Therapeutics NV (STU:05Y) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Vivoryon Therapeutics NV Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Vivoryon Therapeutics NV's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivoryon Therapeutics NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (STU:05Y) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

VVY:Netherlands 0R3M:UK 05Y:Germany

Address

Weinbergweg 22, Halle, SN, DEU, 06120

Website

https://www.vivoryon.com

Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.

Vivoryon Therapeutics NV Headlines

No Headlines